Josh Riggs, CEO of Insight Molecular Diagnostics IMDX, has filed 1 purchase and 0 sales on the open market. The latest trade was on 03/26.

JR

JR

Josh Riggs

CEO and President

Company

Insight Molecular Diagnostics IMDX

First filing

23/01/19

Trades

12 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

03/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Insight Molecular DiagnosticsIMDX	Open-market buy	24/04/11	24/04/15	3,390 sh	$2.95	$10,000.5	+2947.8%